Sector Chart ORIC Pharmaceuticals, Inc. Börse Stuttgart

Stocks

4TZ

US68622P1093

Biotechnology & Medical Research

Market Closed - Börse Stuttgart 15:56:23 2026-08-31 EDT			5-day change	1st Jan Change
11.10 ^EUR	-2.33%		-5.68%	+64.78%

08-28	Oric Pharmaceuticals Insider Sold Shares Worth $1,053,814, According to a Recent SEC Filing	MT
08-03	ORIC Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
ORIC PHARMACEUTICALS, INC.	1.37B	-	-	-	-	-
WUXI APPTEC CO., LTD.	69.54B
ARGENX SE	64.97B
WUXI BIOLOGICS (CAYMAN) INC.	26.51B
INSMED INCORPORATED	25.89B					-
BIONTECH SE	25.64B					-